← Leaderboards
Jeffery Lynn Keene
Galera Therapeutics, Llc
$546,697
Attributed
$1,093,393
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $868.7K · FY2017–20$1M$750K$500K$250K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,093,393 · 1
By mechanism
R44$1,093,393 · 1
Top collaborators
- Michael D Story2 shared
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareEnrollmentAnimalsAntitumor EffectAnimal ModelBiologicalCancer PatientCancer TherapyChemokineChest Wall StructureBaseCisplatinClinical ResearchClinical TrialsCohortCytokineDesignDiagnostic Radiologic ExaminationDiffusionDoseEarly TreatmentEffectivenessChi-Square TestsEpithelial Cells